--- title: "Microdosing GLP-1 Medications: What It Means & the Risks (2026)" description: "Microdosing a GLP-1 means using a smaller-than-standard dose to limit side effects or cost. It's off-label, evidence is limited, and results are usually smaller. Here's what to know." canonical: https://glpeak.ai/answers/glp-1-microdosing reviewer: Sydney Duong, RD, GLPeak Clinical Lead last_updated: 2026-06-17 category: dosing --- # Microdosing GLP-1 Medications: What It Means & the Risks (2026) > **Quick answer:** "Microdosing" a GLP-1 means deliberately using a smaller-than-standard dose — often the starting/titration dose or less — to reduce side effects, save money, or maintain weight. It is not an FDA-approved strategy, the evidence for sub-therapeutic dosing is limited, and weight-loss results are usually smaller and less predictable. Some people similarly "half-dose" by splitting a dose. Any deviation from your prescribed dose should be decided with your prescriber, and splitting compounded vials adds dosing-accuracy and sterility risks. ## What people mean by microdosing There's no official medical definition. In practice, "microdosing" usually means taking less than the standard labeled dose of a GLP-1 such as semaglutide (Ozempic, Wegovy) or tirzepatide (Mounjaro, Zepbound) — for example staying at a starting dose like 0.25 mg semaglutide or 2.5 mg tirzepatide, or going below it. It is distinct from the normal titration schedule, where everyone starts low for tolerance and steps up over weeks. Microdosing is intentionally staying low (or lower) rather than climbing to a therapeutic dose. ## Why people try it - To reduce side effects — nausea, constipation, and fatigue are usually worst right after a dose increase. - To save money — stretching a vial or pen across more weeks lowers cost per week. - To maintain weight after reaching a goal, rather than continuing a full dose. - Sensitivity — some people report meaningful appetite changes even at low doses. ## What the evidence says The pivotal weight-loss and diabetes trials studied specific therapeutic doses reached through titration — not sub-therapeutic "micro" doses. So the predictable, published results (for example the STEP and SURMOUNT trials) apply to the standard doses, not to microdosing. That doesn't mean low doses do nothing, but it does mean results are less certain: smaller average weight loss, more variability, and no trial-backed schedule. Maintenance dosing after weight loss is an area of active research and should be individualized by a prescriber. ## Half-dosing and splitting doses "Half-dosing" usually means taking half of a standard dose — for tolerance or to make a supply last longer. With pre-filled pens (Ozempic, Wegovy, Mounjaro, Zepbound), dialing a non-standard amount isn't how the devices are designed to work, so this is mostly discussed with compounded vials drawn into insulin syringes. Splitting compounded vials adds two real risks: dosing accuracy (small measurement errors are proportionally larger at low volumes) and sterility (every additional draw and storage day is another chance for contamination). If you and your prescriber do reduce a dose, the GLPeak dosage calculator can help you convert milligrams to syringe units accurately. ## Talk to your prescriber first Microdosing and half-dosing are off-label self-adjustments. The safest path is to discuss your goal — fewer side effects, lower cost, or maintenance — with your prescriber, who can adjust your dose or titration pace deliberately rather than by guesswork. ## Frequently asked questions ### How do you half-dose Ozempic or Wegovy? Pre-filled Ozempic and Wegovy pens aren't designed to deliver custom half-doses, so half-dosing is mostly discussed with compounded semaglutide measured in an insulin syringe. Any dose reduction should be decided with your prescriber; if you do reduce a dose, use a tool like the GLPeak dosage calculator to convert milligrams to syringe units accurately. ### Is microdosing a GLP-1 safe? Lower doses generally mean fewer side effects, but microdosing is off-label and unstudied as a strategy, so safety and results aren't guaranteed. Splitting compounded vials also raises dosing-accuracy and sterility concerns. Discuss any change with your prescriber rather than self-adjusting. ### Does microdosing still cause weight loss? It may produce some appetite reduction, but the trial-backed weight-loss results apply to standard therapeutic doses reached through titration, not to sub-therapeutic doses. Expect smaller and less predictable results from microdosing. ### Can you microdose to maintain weight after reaching your goal? Some people and prescribers use a lower maintenance dose after reaching a goal weight, but the best long-term maintenance dose is still being studied and should be individualized. Decide it with your prescriber rather than defaulting to a self-chosen micro dose. ## References - [Wegovy FDA Prescribing Information](https://www.novo-pi.com/wegovy.pdf) - [Zepbound FDA Prescribing Information](https://uspl.lilly.com/zepbound/zepbound.html) --- _Educational only — not medical advice._